SeaStar Medical Appoints Rick Barnett as Chairman of the Board of Directors
November 29, 2022 09:05 ET
|
SeaStar Medical Holding Corporation
DENVER, COLORADO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq:ICU), (“SeaStar Medical” or the “Company”), a medical technology company developing proprietary...
Nemaura Medical Reports Fiscal Second Quarter 2023 Results and Provides Business Update
November 15, 2022 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical to Present at the Bernstein 2ND Annual CGM Disruptors Conference
November 11, 2022 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic...
SeaStar Medical (Nasdaq: ICU) Announces Positive Interim Safety Findings from Ongoing Study Evaluating the Selective Cytopheretic Device (SCD) in Children
November 03, 2022 09:00 ET
|
SeaStar Medical Holding Corporation
Data being presented at the American Society of Nephrology (ASN) Kidney Week 2022 Interim study data show that SCD treatment is safe to use in pediatric patients with Acute Kidney Injury (AKI)...
SeaStar Medical (NASDAQ: ICU) Commences Trading on Nasdaq Capital Market and Outlines Corporate Strategy and Near-Term Catalysts
October 31, 2022 09:25 ET
|
SeaStar Medical Holding Corporation
– Company advancing clinically proven platform therapy, the Selective Cytopheretic Device (SCD), to address the life-threatening consequences of hyperinflammation – SCD lead program in Acute...
Nemaura Receives Provisional Purchase Order from Middle East Licensee TPMENA
October 12, 2022 11:00 ET
|
Nemaura Medical, Inc
LOUGHBOROUGH, ENGLAND, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and...
Nemaura Medical to Present at the 24th Annual H.C. Wainwright Global Investment Conference
September 06, 2022 08:30 ET
|
Nemaura Medical, Inc
Loughborough, England, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable...
Nemaura Medical Reports Fiscal First Quarter 2023 Results and Provides Business Update
August 15, 2022 08:30 ET
|
Nemaura Medical, Inc
Loughborough, England, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical Granted UK Trademark “Meta Score,” a Digital Biomarker Term for its Metabolic Health Program
July 21, 2022 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, July 21, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2022
June 30, 2022 08:00 ET
|
Nemaura Medical, Inc
Loughborough, England, June 30, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...